Christopher Lai

Amministratore Delegato presso METIS TECHBIO CO., LTD.

Patrimonio netto: 289 M $ in data 30/06/2026

36 anni

Health Technology

Producer Manufacturing

Process Industries

Profilo

Christopher Lai was the founder of AquaFresco, Inc., founded in 2015, and held the title of Chief Technology Officer.
Dr. Lai is the founder of Metis Pharmaceuticals, founded in 2019, and holds the titles of General Manager and Executive Director.
Dr. Lai is the founder of Metis TechBio Co., Ltd., founded in 2020, and holds the titles of Chairman and Chief Executive Officer.
Dr. Lai is also the founder of METiS Therapeutics, Inc...

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valutazione	Data di valutazione
METIS TECHBIO CO., LTD. CLASS H 10,26%	10/06/2026	111.166.572 ( 10,26% )	218 M $	30/06/2026
METIS TECHBIO CO., LTD. 36,55%	13/05/2026	36.400.278 ( 36,55% )	71 M $	30/06/2026

Posizioni attive di Christopher Lai

Società	Posizione	Inizio
METIS TECHBIO CO., LTD.	Amministratore Delegato	10/01/2020
METiS Therapeutics, Inc. METiS Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for patients with diseases	Amministratore Delegato	-
Metis Pharmaceuticals Metis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Provides an artificial intelligence-driven drug formulation platform	Fondatore	01/01/2019

Tutte le posizioni attive di Christopher Lai

Precedenti posizioni note di Christopher Lai

Società	Posizione	Fine
AquaFresco, Inc. AquaFresco, Inc. Industrial MachineryProducer Manufacturing Designs and develops water recycling technology	Fondatore	-

Vedi nel dettaglio l'esperienza di Christopher Lai

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Vedi nel dettaglio l'esperienza di Christopher Lai

Società collegate

Aziende private	4
AquaFresco, Inc. AquaFresco, Inc. Industrial MachineryProducer Manufacturing Designs and develops water recycling technology	Producer Manufacturing
Metis Pharmaceuticals Metis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Provides an artificial intelligence-driven drug formulation platform	Health Technology
METiS Therapeutics, Inc. METiS Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for patients with diseases	Health Technology
Hangzhou Jitai Pharmaceutical Technology Co. Ltd. Hangzhou Jitai Pharmaceutical Technology Co. Ltd. Chemicals: Major DiversifiedProcess Industries Operates as an investment holding company whose subsidiaries provides AI based nanomaterials delivery and application services	Process Industries